SEC 13F Intelligence

Palo Alto Investors LP / MNTA

Palo Alto Investors LP’s Momenta Pharmaceuticals Inc Position

Does Palo Alto Investors LP own Momenta Pharmaceuticals Inc (MNTA)? Not currently — the last reported position was 1.48M shares worth $49M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q2 2020
Shares
1.48M
% of Portfolio
+2.96%
Quarters Held
7
position exited

Position History MNTA

Reported value by quarter
Q4 ’18: $20MQ4 ’18Q1 ’19: $27MQ1 ’19Q2 ’19: $24MQ2 ’19Q3 ’19: $23MQ3 ’19Q4 ’19: $33MQ4 ’19Q1 ’20: $42MQ1 ’20Q2 ’20: $49MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20201.48M$49M+2.96%
Q1 20201.53M$42M+3.48%
Q4 20191.69M$33M+1.83%
Q3 20191.76M$23M+1.52%
Q2 20191.92M$24M+1.16%
Q1 20191.84M$27M+1.12%
Q4 20181.84M$20M+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of MNTA.